Fisher Andrew
- SEC CIK
- 0002014301
No open-market purchases or sales filed in the past year.
Current role at each company
- VRNA Verona Pharma plcGeneral Counselas of Oct 8, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Fisher Andrew as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 5, 2025 (view filing) | Aug 1 | 4 days | Fisher AndrewGeneral Counsel | SSale | −9.58K | $13.14 | −$125.9K | −2.2%417.9K after | |
| Jun 18, 2025 (view filing) | Jun 16 | 2 days | Fisher AndrewGeneral Counsel | SSale | −80.0K | $11.53 | −$922.4K | −18.2%360.0K after | 10b5-1 |
| May 16, 2025 (view filing) | May 15 | 1 day | Fisher AndrewGeneral Counsel | SSale | −80.0K | $8.57 | −$685.6K | −18.2%360.0K after | From original |
| May 1, 2025 (view filing) | Apr 29 | 2 days | Fisher AndrewGeneral Counsel | SSale | −26.1K | $8.98 | −$234.1K | −6.8%360.0K after |